Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized phase III study of TS-1 alone versus TS-1 plus CDDP in advanced gastric cancer

Trial Profile

Randomized phase III study of TS-1 alone versus TS-1 plus CDDP in advanced gastric cancer

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SPIRITS
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 21 Jan 2017 Results (n=1248) of a combined analysis from SPIRITS, TOP-002 and START trials, presented at the 2017 Gastrointestinal Cancers Symposium
    • 01 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 01 Mar 2008 Results published in Lancet Oncology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top